Summarized by Masters of Longevity from Fight Aging!.
This review article examines preclinical animal research on mesenchymal stem cell approaches for neurodegenerative conditions, highlighting the types of studies and therapeutic signals evaluated.
Key Takeaways
- The review included 37 preclinical studies covering Parkinson’s, Alzheimer’s, and stroke models.
- Specific MSC-derived miRNAs such as miR-133b, miR-146a, miR-17-92, and miR-223 showed neuroprotective effects in animals.
- MSCs and their miRNAs reduced neuroinflammation, apoptosis, and pathological markers including α-synuclein and amyloid-β in models.
